JP2020522571A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020522571A5 JP2020522571A5 JP2020516959A JP2020516959A JP2020522571A5 JP 2020522571 A5 JP2020522571 A5 JP 2020522571A5 JP 2020516959 A JP2020516959 A JP 2020516959A JP 2020516959 A JP2020516959 A JP 2020516959A JP 2020522571 A5 JP2020522571 A5 JP 2020522571A5
- Authority
- JP
- Japan
- Prior art keywords
- item
- patient
- day
- pharmaceutical composition
- administered
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- BMAAMIIYNNPHAB-UHFFFAOYSA-N COc(cc1)c(COc(c(OC)c2)cc(N(C(c3c(C(O)=O)[s]cc3N3)=O)C3=O)c2F)c(F)c1F Chemical compound COc(cc1)c(COc(c(OC)c2)cc(N(C(c3c(C(O)=O)[s]cc3N3)=O)C3=O)c2F)c(F)c1F BMAAMIIYNNPHAB-UHFFFAOYSA-N 0.000 description 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023084336A JP7657855B2 (ja) | 2017-06-05 | 2023-05-23 | 子宮内膜症の治療のためのゴナドトロピン放出ホルモンアンタゴニスト投与計画 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762515268P | 2017-06-05 | 2017-06-05 | |
| US62/515,268 | 2017-06-05 | ||
| PCT/EP2018/064768 WO2018224498A1 (en) | 2017-06-05 | 2018-06-05 | Gonadotropin-releasing hormone antagonist dosing regimens for the treatment of endometriosis |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023084336A Division JP7657855B2 (ja) | 2017-06-05 | 2023-05-23 | 子宮内膜症の治療のためのゴナドトロピン放出ホルモンアンタゴニスト投与計画 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020522571A JP2020522571A (ja) | 2020-07-30 |
| JP2020522571A5 true JP2020522571A5 (https=) | 2021-07-26 |
| JP7348171B2 JP7348171B2 (ja) | 2023-09-20 |
Family
ID=62620835
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020516959A Active JP7348171B2 (ja) | 2017-06-05 | 2018-06-05 | 子宮内膜症の治療のためのゴナドトロピン放出ホルモンアンタゴニスト投与計画 |
| JP2023084336A Active JP7657855B2 (ja) | 2017-06-05 | 2023-05-23 | 子宮内膜症の治療のためのゴナドトロピン放出ホルモンアンタゴニスト投与計画 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023084336A Active JP7657855B2 (ja) | 2017-06-05 | 2023-05-23 | 子宮内膜症の治療のためのゴナドトロピン放出ホルモンアンタゴニスト投与計画 |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US11980621B2 (https=) |
| EP (1) | EP3634418A1 (https=) |
| JP (2) | JP7348171B2 (https=) |
| KR (2) | KR20250117836A (https=) |
| CN (1) | CN110996956A (https=) |
| AU (2) | AU2018280742B2 (https=) |
| CA (1) | CA3066190A1 (https=) |
| EA (1) | EA201992612A1 (https=) |
| MA (1) | MA49256A (https=) |
| MX (1) | MX2019014483A (https=) |
| SG (1) | SG11201911598WA (https=) |
| WO (1) | WO2018224498A1 (https=) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2912929T5 (en) | 2016-09-30 | 2025-05-09 | Sumitomo Pharma Switzerland Gmbh | Methods of treating uterine fibroids and endometriosis |
| KR102884301B1 (ko) | 2017-06-05 | 2025-11-11 | 깃세이 야쿠힌 고교 가부시키가이샤 | 자궁 근종을 치료하고 월경혈량을 감소시키기 위한 고나도트로핀 방출 호르몬 길항제 투약 요법 |
| EA201992612A1 (ru) | 2017-06-05 | 2020-05-20 | Обсева С.А. | Схемы применения антагониста гонадотропин-высвобождающего гормона для лечения эндометриоза |
| CA3117092A1 (en) | 2018-10-29 | 2020-05-07 | ObsEva S.A. | Compositions and methods for the treatment of adenomyosis and rectovaginal endometriosis |
| CN114466665A (zh) * | 2019-08-08 | 2022-05-10 | 奥布赛瓦股份公司 | 用于治疗雌激素依赖性病症的组合物和方法 |
| CN113384581B (zh) * | 2020-03-12 | 2023-11-14 | 成都倍特药业股份有限公司 | 一种包含促性腺激素释放激素拮抗剂的药物组合物 |
| CA3185151A1 (en) | 2020-05-29 | 2021-12-02 | Myovant Sciences Gmbh | Combination solid oral dosage forms of gonadotropin-releasing hormone antagonists |
| WO2022101303A1 (en) * | 2020-11-11 | 2022-05-19 | Myovant Sciences Gmbh | Methods of administering relugolix |
| CN116940575A (zh) * | 2021-02-23 | 2023-10-24 | 深圳市康哲药业有限公司 | 噻吩并嘧啶二酮类化合物及其应用 |
| CN115232144B (zh) * | 2021-04-22 | 2024-04-02 | 长春金赛药业有限责任公司 | 含氮稠环类衍生物、药物组合物及其制备方法和应用 |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5342760A (en) | 1992-06-10 | 1994-08-30 | Abbott Laboratories | Determination of estradiol by competitive immunoassay |
| US5663054A (en) | 1995-03-03 | 1997-09-02 | Abbott Laboratories | Determination of steroids by competitive immunoassay |
| US7109171B2 (en) | 2000-02-28 | 2006-09-19 | Praecis Pharmaceuticals Inc. | Methods for treating FSH related conditions with GnRH antagonists |
| CN1186326C (zh) | 2000-07-05 | 2005-01-26 | 山之内制药株式会社 | 丙－1,3－二酮衍生物 |
| US7300935B2 (en) | 2003-01-29 | 2007-11-27 | Takeda Pharmaceutical Company | Thienopyrimidine compounds and use thereof |
| CN100424078C (zh) | 2003-07-07 | 2008-10-08 | 纽罗克里生物科学有限公司 | 作为促性激素释放激素受体拮抗剂的嘧啶-2,4-二酮衍生物 |
| SI1864976T1 (sl) | 2005-03-31 | 2012-12-31 | Astellas Pharma Inc. | Propan-1,3-dionski derivat ali njegova sol |
| KR101384132B1 (ko) | 2005-10-19 | 2014-04-10 | 깃세이 야쿠힌 고교 가부시키가이샤 | 축합 복소환 유도체, 그것을 함유하는 의약 조성물 및 그의약 용도 |
| US8765948B2 (en) | 2007-11-07 | 2014-07-01 | Neurocrine Biosciences, Inc. | Processes for the preparation of uracil derivatives |
| SG183243A1 (en) | 2010-02-10 | 2012-09-27 | Kissei Pharmaceutical | Salt of fused heterocyclic derivative and crystal thereof |
| AP2014007738A0 (en) | 2012-01-16 | 2014-07-31 | Bayer Ip Gmbh | Spiroindoline derivatives as gonadotropin-releasing hormone receptor antagonists |
| US20130224771A1 (en) | 2012-02-21 | 2013-08-29 | Northwestern University | Anti-mullerian hormone detection in whole blood |
| KR20150048762A (ko) | 2012-09-07 | 2015-05-07 | 아스텔라스세이야쿠 가부시키가이샤 | 술포닐아미딘 화합물의 제조법 |
| WO2014042176A1 (ja) | 2012-09-14 | 2014-03-20 | キッセイ薬品工業株式会社 | 縮合複素環誘導体の製造方法およびその製造中間体 |
| AR092707A1 (es) | 2012-09-28 | 2015-04-29 | Takeda Pharmaceuticals Co | Metodo de produccion de derivado de tienopirimidina |
| US10881659B2 (en) | 2013-03-15 | 2021-01-05 | Abbvie Inc. | Methods of treating heavy menstrual bleeding |
| AR095785A1 (es) | 2013-04-09 | 2015-11-11 | Bayer Pharma AG | Derivados de espiroindolina y composiciones farmacéutica de los mismos |
| AU2016317955B2 (en) | 2015-09-01 | 2021-05-20 | Abbvie Inc. | Methods of administering Elagolix |
| TWI746613B (zh) * | 2016-08-08 | 2021-11-21 | 日商橘生藥品工業股份有限公司 | 子宮內膜病症治療劑之用法及用量 |
| ES2912929T5 (en) | 2016-09-30 | 2025-05-09 | Sumitomo Pharma Switzerland Gmbh | Methods of treating uterine fibroids and endometriosis |
| EA201992612A1 (ru) | 2017-06-05 | 2020-05-20 | Обсева С.А. | Схемы применения антагониста гонадотропин-высвобождающего гормона для лечения эндометриоза |
| KR102884301B1 (ko) | 2017-06-05 | 2025-11-11 | 깃세이 야쿠힌 고교 가부시키가이샤 | 자궁 근종을 치료하고 월경혈량을 감소시키기 위한 고나도트로핀 방출 호르몬 길항제 투약 요법 |
| SG11202104053TA (en) | 2018-11-07 | 2021-05-28 | ObsEva SA | Compositions and methods for the treatment of estrogen-dependent disorders |
-
2018
- 2018-06-05 EA EA201992612A patent/EA201992612A1/ru unknown
- 2018-06-05 EP EP18731378.8A patent/EP3634418A1/en active Pending
- 2018-06-05 MX MX2019014483A patent/MX2019014483A/es unknown
- 2018-06-05 KR KR1020257024754A patent/KR20250117836A/ko active Pending
- 2018-06-05 WO PCT/EP2018/064768 patent/WO2018224498A1/en not_active Ceased
- 2018-06-05 CN CN201880050650.3A patent/CN110996956A/zh active Pending
- 2018-06-05 MA MA049256A patent/MA49256A/fr unknown
- 2018-06-05 US US16/619,776 patent/US11980621B2/en active Active
- 2018-06-05 AU AU2018280742A patent/AU2018280742B2/en active Active
- 2018-06-05 JP JP2020516959A patent/JP7348171B2/ja active Active
- 2018-06-05 KR KR1020197038977A patent/KR102839190B1/ko active Active
- 2018-06-05 CA CA3066190A patent/CA3066190A1/en active Pending
- 2018-06-05 SG SG11201911598WA patent/SG11201911598WA/en unknown
-
2023
- 2023-05-23 JP JP2023084336A patent/JP7657855B2/ja active Active
-
2024
- 2024-03-14 AU AU2024201701A patent/AU2024201701B2/en active Active
- 2024-04-12 US US18/634,241 patent/US20240293414A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020522571A5 (https=) | ||
| TWI314053B (en) | Use of compounds that are effective as selective opiate receptor modulators | |
| KR20240099142A (ko) | 병용 요법 | |
| JP2023113715A (ja) | 子宮内膜症の治療のためのゴナドトロピン放出ホルモンアンタゴニスト投与計画 | |
| JP2020522525A5 (https=) | ||
| AU2009238379A1 (en) | Folic acid-containing pharmaceutical compositions, and related methods and delivery systems | |
| US20230018765A1 (en) | A 19-nor c3,3-disubstituted c21-n-pyrazolyl steroid and methods of use thereof | |
| CA2746787A1 (en) | Method of increasing testosterone and related steroid concentrations in women | |
| NO334991B1 (no) | Blandinger for å øke testosteron og beslektede konsentrasjoner av steroid hos kvinner | |
| EP0747054B1 (en) | Methods for minimizing bone loss | |
| US20040067918A1 (en) | Combination of an aldosterone receptor antagonist and nicotinic acid or a nicotinic acid derivative | |
| JP2003509467A5 (https=) | ||
| JP2005526022A5 (ja) | 関節リウマチの処置 | |
| JP2024529777A (ja) | ＡＲＮｉとカルシウムイオンアンタゴニストとの医薬組成物および応用 | |
| CN102421450B (zh) | 治疗虚弱的方法 | |
| TWI835716B (zh) | 治療良性前列腺增殖徵候與症狀之四氫環戊[b]吲哚化合物與磷酸二酯酶抑制劑 | |
| MXPA04009039A (es) | Combinacion de un antagonista de los receptores de la aldosterona y un agente secuestrante de los acidos biliares. | |
| JP2006306872A (ja) | 選択的エストロゲン受容体修飾因子及びアロマターゼ阻害剤の組み合わせよりなる医薬組成物及び方法 | |
| AU2005269052A1 (en) | Combination comprising a BCRP inhibitor and 4-(4-methylpiperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl)pyrimidin-2-ylamino)phenyl]-benzamide | |
| JP2026500731A (ja) | 医薬組合せおよび医薬組成物、ならびにその使用方法 | |
| Agrawal et al. | Topical Nitroglycerin: A New and Safe Treatment Option for Osteoporosis | |
| Agarwal et al. | Topical Nitroglycerin for Osteoporosis: Old Drug New Application | |
| JP2005523302A (ja) | アルドステロン受容体アンタゴニストおよびフィブリン酸誘導体の併用 | |
| TW200906406A (en) | Use of a compound that is a neurokinin A NK2 receptor antagonist for the preparation of medicaments for use in the prevention and treatment of sexual dysfunctions | |
| JP2005531622A5 (https=) |